XML 80 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of Current and Deferred Tax Provision
A summary of the Company’s current and deferred tax provision is as follows:
 
 
  
Year Ended December 31,
 
 
  
2021
 
  
2020
 
Current income tax expense (benefit):
  
     
  
     
Federal
 
$
 
 
$
 
State
     17        17  
    
 
 
    
 
 
 
Total current income tax expense (benefit)
     17        17  
Deferred income tax expense (benefit):
                 
Federal
     1        (2,366
State
     2        (2,351
    
 
 
    
 
 
 
Total deferred tax expense (benefit)
    
3
       (4,717
    
 
 
    
 
 
 
Total (benefit) from income taxes
  
$
20      $ (4,700
    
 
 
    
 
 
 
Schedule of Reconciliation of the U.S. Federal Statutory Income Tax
A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 
 
  
Year Ended December 31,
 
 
  
2021
 
 
2020
 
Federal statutory income tax rate
     21.0      21.0
State income taxes, net of federal benefits
     9.8      3.0
Research and development tax credits
     1.5      1.0
Interest accretion expense
     8.6      5.5
Change in valuation allowance
     (46.1 )%       (21.6 )% 
Mark to market warrant
     2.8        (5.7 )% 
Other permanent items
     2.4      (1.0 )% 
Effective income tax rate
     (0.0
)
     2.2
    
 
 
    
 
 
 
Schedule of Net Deferred Tax Liabilities
Net deferred tax liabilities as of years ended December 31, 2021 and 2020 consisted of the following:
 
 
  
Year Ended December 31,
 
 
  
2021
 
  
2020
 
Deferred tax assets:
                 
Net operating loss carryforwards
   $ 88,327      $ 53,495  
Research and development tax credit carryforwards
     7,672        5,673  
Stock-based compensation expense
     11,748        1,304  
Startup costs
     697        729  
Intangible assets
     4,471        4,544  
Deferred revenue
     1,103        3,226  
Unicap
     6        6  
Imputed interest on contingent payments
     4,410        2,340  
Legal fee capitalization and amortization
     1,550        1,587  
Other
     1,535        1,158  
    
 
 
    
 
 
 
Total deferred tax assets
     121,519        74,062  
Deferred tax liabilities:
                 
In-process
research and development
     (29,232      (27,930
    
 
 
    
 
 
 
Total deferred tax liabilities
     (29,232      (27,930
    
 
 
    
 
 
 
Valuation allowance
     (92,297      (46,139
    
 
 
    
 
 
 
Net deferred tax liabilities
   $ (10    $ (7
    
 
 
    
 
 
 
Schedule of Unrecognized Tax Benefits
A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:

 
 
  
Unrecognized

Tax Benefits
 
Balance at December 31, 2019
   $ 786  
    
 
 
 
Increase related to prior year tax positions
     —    
Increase related to current year tax provisions
     242  
Decrease for settlements
     —    
Reduction for lapse of applicable statute of limitations
     —    
    
 
 
 
Balance at December 31, 2020
   $ 1,028  
    
 
 
 
Increase related to prior year tax positions
     —    
Increase related to current year tax provisions
    
242

 
Decrease for settlements
     —    
Reduction for lapse of applicable statute of limitations
     —    
    
 
 
 
Balance at December 31, 2021
   $ 1,270